ICU入院时血清去甲肾上腺素水平与ICU获得性谵妄风险的关系:褪黑素评估降低ICU试验炎症的二次分析
本研究为褪黑素评估降低ICU试验的二次分析,纳入81例在ICU入院时测量血清儿茶酚胺水平的ICU患者。分别在接受(Ex[+]组)与未接受(Ex[-]组)外源性儿茶酚胺的患者中评估入院时血清儿茶酚胺水平与ICU获得性谵妄风险的关联。Ex(-)组入院时血清去甲肾上腺素水平与ICU获得性谵妄风险显著相关(OR 2.58;95%CI 1.02-6.52;P=0.046),Ex(+)组无显著关联(OR 1.02;95%CI 0.88-1.18;P=0.823),且交互作用显著(P交互=0.017)。结论提示该关联在是否接受外源性儿茶酚胺的患者间存在差异。
要点
- 在未接受外源性儿茶酚胺的ICU患者中,入院时血清去甲肾上腺素水平与ICU获得性谵妄风险显著相关(OR 2.58;95%CI 1.02-6.52;P=0.046)。
- 在接受外源性儿茶酚胺的ICU患者中,入院时血清去甲肾上腺素水平与ICU获得性谵妄风险无显著关联(OR 1.02;95%CI 0.88-1.18;P=0.823)。
- 血清去甲肾上腺素水平与外源性儿茶酚胺使用状态对ICU获得性谵妄风险存在显著交互作用(P交互=0.017)。
- 该关联在是否接受外源性儿茶酚胺的患者间存在差异,解读入院儿茶酚胺水平时需区分外源性使用状态。
适用人群与场景
- ICU患者,且在ICU入院时测量了血清儿茶酚胺水平。
- 按ICU入院时是否接受外源性儿茶酚胺分为Ex[+]组(接受)与Ex[-]组(未接受)。
研究设计与关键结果
- 研究类型:随机临床试验(褪黑素评估降低ICU试验炎症)的二次分析;样本量81例;场景为学术医院ICU;无干预。
- Ex(-)组:入院时血清去甲肾上腺素水平与ICU获得性谵妄风险显著相关(OR 2.58;95%CI 1.02-6.52;P=0.046)。
- Ex(+)组:入院时血清去甲肾上腺素水平与ICU获得性谵妄风险无显著关联(OR 1.02;95%CI 0.88-1.18;P=0.823)。
- 交互作用:血清去甲肾上腺素水平与外源性儿茶酚胺使用/未使用对ICU获得性谵妄风险存在显著交互作用(P交互=0.017)。
证据类型、等级与局限
- 证据类型:随机临床试验的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,入院时血清去甲肾上腺素水平与未接受外源性儿茶酚胺患者的ICU获得性谵妄风险相关,而在先前接受外源性儿茶酚胺者中未观察到该关联。
- 作者认为,入院时血清儿茶酚胺水平与ICU获得性谵妄风险的关联在是否接受外源性儿茶酚胺的患者间存在差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Abnormal secretion of catecholamines is well known to cause delirium. In particular, disturbances of catecholamine balance can cause ICU-acquired delirium. The aim of this study was to evaluate the association between the serum levels of catecholamines and the risk of occurrence of ICU-acquired delirium separately in patients who had/had not received exogenous catecholamines before ICU admission.
DESIGN: A secondary analysis of the data of 81 patients enrolled in our previous randomized clinical trial.
SETTING: ICU of an academic hospital.
PATIENTS: ICU patients in whom the serum levels of catecholamines were measured at ICU admission.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We evaluated the association between the serum levels of catecholamines measured at ICU admission and the risk of ICU-acquired delirium separately in patients who had received exogenous catecholamines at ICU admission (Ex[+] group) and those who had not received exogenous catecholamines (Ex[-] group). The serum levels of norepinephrine measured at ICU admission were significantly associated with the risk of ICU-acquired delirium in the Ex(-) group (odds ratio, 2.58; 95% CI, 1.02-6.52; p = 0.046), but not in the Ex(+) group (odds ratio, 1.02; 95% CI, 0.88-1.18; p = 0.823). Furthermore, there was a statistically significant interaction effect between the serum levels of norepinephrine and the use/nonuse of exogenous catecholamines at ICU admission in relation to the risk of occurrence of ICU-acquired delirium (p interaction = 0.017).
CONCLUSIONS: The serum levels of norepinephrine measured at admission were associated with the risk of occurrence of ICU-acquired delirium in patients who had not received exogenous catecholamines at ICU admission, whereas no such association was observed in those who had received exogenous catecholamines previously. Thus, the association between the serum levels of catecholamines measured at admission and the risk of ICU-acquired delirium differed between patients who had/had not received exogenous catecholamines at ICU admission.
参考来源
- Yasuda Y, Nishikimi M, Nishida K, et al. Relationship Between Serum Norepinephrine Levels at ICU Admission and the Risk of ICU-Acquired Delirium: Secondary Analysis of the Melatonin Evaluation of Lowered Inflammation of ICU Trial. Crit Care Explor. 2020. PMID: 32211614. doi:10.1097/CCE.0000000000000082
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。